In this episode, Drs. Erin Michos and Leslie Cho discuss the research presented at ACC.24 related to statin intolerance and bempedoic acid. Dr. Cho’s research publication “Characteristics and Outcomes for Statin Intolerant Women Receiving Bempedoic Acid in The Clear Outcomes Trial” is discussed, as well as lipid management for women, Hispanic, Latinx, and obese patients in the CLEAR Outcomes Trial.

This podcast is part of Bempedoic Acid: New Evidence Transforming the LDL-C Treatment Landscape grant initiative. 

Educational grant support is provided by Esperion. 

Related References:

1. Cho L, Plutzky J, Brennan D, et al. Impact of Bempedoic Acid on Cardiovascular Outcomes by Sex. Circulation. 2024;149:1775-1777. doi: 10.1161/CIRCULATIONAHA.123.067691
2. Rodriguez F, Cho L, Foody J, et al. Characteristics and Outcomes for Hispanic/Latinx Participants With Statin Intolerance Receiving Bempedoic Acid. J Am Coll Cardiol. 2024;83:2130-2132. doi: 10.1016/j.jacc.2024.03.390
3. Bays HE, Bloedon L, Brennan D, et al. Bempedoic Acid for Prevention of Cardiovascular Events in People With Obesity: A CLEAR Outcomes Subset Analysis. J Am Heart Assoc. 2025;14:e037898. doi: 10.1161/JAHA.124.037898